Notably, upregulation of SLC6A8 was found to be inversely related to the overall survival in cancer of lung, breast and skin, relapse free survival (RFS) in cancer of the lung and breast, and distant metastasis-free survival (DMFS) in breast cancer. Here, SLC6A8 is linked to breast cancer.